0.00 INTERPRETATION
0.01 Definitions
0.01.01 Activities
0.01.02 Agreement
0.01.03 Breach
0.01.04 Change in Control
0.01.05 Clinical Trials
0.01.06 Confidential Information
0.01.07 Encumber or Encumbrance
0.01.08 Event of Default
0.01.09 File Preparation
0.01.10 Force Majeure
0.01.11 Fundamental Provisions
0.01.12 Industrial Property
0.01.13 Intellectual Property
0.01.14 Legal Representatives
0.01.15 PARTY
0.01.16 Person
0.01.17 Phase
0.01.18 Prime Rate
0.01.19 Product
0.01.20 Purchase Order
0.01.21 Related Person
0.01.22 Report
0.01.23 Results
0.01.24 Sample
0.01.25 Schedule
0.01.26 Specifications
0.01.27 Subsidiary
0.01.28 Territory
0.01.29 Trial Program
0.02 Precedence
0.02.01 Entire Understanding
0.02.02 Interpretative Conflict
0.03 Jurisdiction
0.03.01 Governing Law
0.03.02 Non-compliance
0.04 Miscellaneous
0.04.01 Cumulative Rights
0.04.02 Time and Dates
0.04.03 Financial References
0.04.04 References within Agreement
0.04.05 Gender and Number
0.04.06 Headings
0.04.07 Presumptions
0.04.08 Knowledge
0.04.09 Approval
0.04.10 GAAP
1.00 PURPOSE
1.01 Grant
1.02 Conditions
1.02.01 Required by RESEARCH CENTER
1.02.02 Required by CLIENT
1.02.03 Choice
2.00 CONSIDERATION
2.01 Fees
2.02 Disbursements
3.00 TERMS OF PAYMENT
3.01 Payments
3.01.01 Delivery of Invoice
3.01.02 Method
3.02 Advance
3.03 Failure to Pay
3.04 Interest
4.00 SECURITY
4.01 In favour of RESEARCH CENTER
4.02 In favour of CLIENT
5.00 MUTUAL REPRESENTATIONS AND WARRANTIES
5.01 Status
5.02 Authority
5.03 Binding Agreement
5.04 Canadian Resident
5.05 Commission
5.06 Insurance
5.07 Nominee
5.08 Fundamental Provisions
5.09 Disclosure
6.00 REPRESENTATIONS AND WARRANTIES OF THE RESEARCH CENTER
6.01 Status
6.02 Authority
6.03 Binding Agreement
6.04 Insurance
6.05 Nominee
6.06 Fundamental Provisions
6.07 Disclosure
6.08 Resources
6.09 Conflict of Interest
6.10 License
6.11 Error and Omission Insurance
6.12 Labour Dispute
7.00 REPRESENTATIONS AND WARRANTIES OF THE CLIENT
7.01 Status
7.02 Authority
7.03 Binding Agreement
7.04 Insurance
7.05 Nominee
7.06 Fundamental Provisions
7.07 Disclosure
7.08 Industrial Property
7.09 Intellectual Property
7.10 Rights
8.00 MUTUAL DUTIES AND OBLIGATIONS
8.01 Confidential Information
8.01.01 Undertaking
8.01.02 End of Agreement
8.02 Insurance
8.02.01 Insured Risks
8.02.02 Amount of Coverage
8.02.03 Issuer
8.02.04 Co-insured
8.02.05 No Limitation
8.03 Indemnification
8.03.01 “Loss”
8.03.02 Scope
8.03.03 Procedure
8.03.04 Deductible
8.03.05 Limitation on Claims
8.04 Disclosure of Agreement
9.00 DUTIES AND OBLIGATIONS OF THE RESEARCH CENTER
9.01 Acceptation
9.01.01 Formal Acceptation
9.01.02 Implied Acceptation
9.02 Performance of the Purchase Orders
9.02.01 Purchase Order
9.02.02 Compliance
9.02.03 No Obligation to Produce Results
9.02.04 No Warranty Regarding CLIENT’s Product
9.02.05 Software
9.02.06 Compliance with Laws
9.02.07 RESEARCH CENTER Team
9.02.08 Personal Performance and Sub-contracting
9.02.09 Location of Performance
9.02.10 Supervision of Clinical Trials
9.02.11 Meetings and Progress Reports
9.02.12 Amendment
9.03 Schedule
9.04 Error and Omission Insurance
9.05 Suspension of services
9.05.01 Notice of suspension
9.05.02 Invoiced Services
9.06 Preparation and Delivery of Documents
9.07 Cooperation
9.08 Display Right and Promotion
9.09 Visits
9.09.01 Laboratories
9.09.02 Subcontractors
9.09.03 Responsability
9.10 Control of Accounts
9.11 Responsibility
9.12 Care
9.13 Results
9.13.01 Communications
9.13.02 Disclosure
9.13.03 Use
9.14 Transfer of Property
9.14.01 Resulting from the Clinical Trials
9.14.02 Resulting from the File Preparation
9.15 Non-competition
9.15.01 Scope
9.15.02 Adjustments
9.15.03 Penalty
9.15.04 Additional Remedy
10.00 DUTIES AND OBLIGATIONS OF THE CLIENT
10.01 Cooperation
10.02 Transfer of Information and Materials
10.03 Insurance
10.04 Transportation
10.05 Meetings and Progress Reports
10.06 Modification
10.07 Report
10.08 Results
10.09 Waiver
10.10 Non-solicitation of Staff
11.00 SPECIAL PROVISIONS
11.01 Assignment
11.01.01 Prohibition
11.01.02 Effect of Breach
11.01.03 Exception
11.02 Force Majeure
11.02.01 No Default
11.02.02 Duty
11.02.03 Rights of Other PARTY
11.03 Relationship
11.03.01 Independent Contractors
11.03.02 No Control over Performance
11.03.03 No Authority to Bind
11.04 Further Assurances
11.05 Remedies
11.05.01 Choices
11.05.02 No Limitations
11.06 Prescription
11.07 Intellectual Property
11.08 Language
12.00 GENERAL PROVISIONS
12.01 Notice
12.02 Dispute Resolution
12.02.01 Good Faith Negotiations
12.02.02 Mediation
12.02.03 Arbitration
12.03 Election
12.04 Counterparts
12.05 Amendment
12.06 Waiver of Rights
12.07 Electronic Transmission
12.08 Language
13.00 TERMINATION
13.01 Mutual Consent
13.02 Unilateral Termination
13.03 Without Notice
13.04 Prior Notice
13.04.01 Event of Default
13.04.02 Suspension
13.05 Cancellation
13.06 Change of Control
14.00 EFFECTIVE DATE
14.01 Retroactivity
14.02 Execution
14.03 Deferral
15.00 DURATION
15.01 Trial Program
15.02 Survival
16.00 SCOPE


SCHEDULE A – EXCERPT FROM A RESOLUTION OF THE RESEARCH CENTER
SCHEDULE B – EXCERPT FROM A RESOLUTION OF THE CLIENT
SCHEDULE 0.01.25 - SCHEDULE